Table of content for "Idecabtagene vicleucel car" (HCPCS Q2055)
General information on the “Q2055” code
HCPCS Code: Q2055
Long Description: Idecabtagene vicleucel, up to 460 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short Description: Idecabtagene vicleucel car
Original information is taken from Q2055 page
Pricing indicators
Pricing Indicator Code 1: 51 – Drugs
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: C – Carrier judgment
Type of service
Berenson-Eggers Type of Service (BETOS): O1D – Chemotherapy
Type Of Service 1: 1 – Medical care
Type Of Service 2: P – Lump sum purchase of DME, prosthetics, orthotics
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20220101
Code Effective Date: 20220101
Action Code: N – No maintenance for this code